M. Kuno

发表

Increasing numbers of CD19 + CD24highCD38high regulatory B cells and pre-germinal center B cells reflect activated autoimmunity and predict future treatment response in patients with untreated immune thrombocytopenia

M. Hino, H. Koh, Y. Nakashima, 2021, International Journal of Hematology.

Severe immune-related complications early after allogeneic hematopoietic cell transplantation for nivolumab-pretreated lymphoma

S. Kurosawa, T. Fukuda, Y. Inamoto, 2018, Bone Marrow Transplantation.

Plasma Levels of Presepsin (Soluble CD14-subtype) as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancies.

M. Hino, H. Koh, Masamichi Hashiba, 2016, Internal medicine.

A Prospective Study of an HLA-Haploidentical Peripheral Blood Stem Cell Transplantation Regimen Based on Modification of the Dose of Posttransplant Cyclophosphamide for Poor Prognosis or Refractory Hematological Malignancies

M. Hino, H. Koh, Y. Nakashima, 2022, Cell transplantation.

Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy

M. Hino, N. Inoue, H. Koh, 2021, Frontiers in Immunology.

Outcomes of hematopoietic cell transplantation for transformed follicular lymphoma

K. Izutsu, A. Maeshima, T. Fukuda, 2021, Hematological oncology.

Risk Factor and Long-Term Outcome Analyses for Acute Limbic Encephalitis and Calcineurin Inhibitor-Induced Encephalopathy in Adults following Allogeneic Hematopoietic Cell Transplantation.

M. Hino, H. Koh, Y. Nakashima, 2021, Transplantation and cellular therapy.

Polatuzumab vedotin combined with rituximab-bendamustine immediately before stem cell mobilization in relapsed diffuse large B-cell lymphoma

M. Hino, H. Koh, Y. Nakashima, 2022, Annals of Hematology.

Effect of donor NKG2D polymorphism on relapse after haploidentical transplantation with post-transplant cyclophosphamide.

M. Hino, H. Koh, Y. Nakashima, 2021, Transplantation and cellular therapy.

Characterization of myeloid neoplasms following allogeneic hematopoietic cell transplantation

S. Yamasaki, T. Miyamoto, M. Onizuka, 2021, American journal of hematology.

Drug interactions and safety profiles with concomitant use of caspofungin and calcineurin inhibitors in allogeneic haematopoietic cell transplantation

M. Hino, H. Koh, Y. Nakashima, 2017, British journal of clinical pharmacology.

Two cases of eosinophilic gastrointestinal disorder due to newly appearing food allergies after cord blood transplantation.

M. Hino, Y. Fujiwara, A. Higashimori, 2023, Transplant immunology.

A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantation

M. Hino, H. Koh, Y. Nakashima, 2021, International Journal of Hematology.

Prognostic significance of low pre-transplant skeletal muscle mass on survival outcomes in patients undergoing hematopoietic stem cell transplantation

S. Kurosawa, T. Fukuda, Y. Inamoto, 2019, International Journal of Hematology.

Delayed immune-related neutropenia with hepatitis by pembrolizumab.

M. Hino, T. Ueda, H. Koh, 2021, Immunotherapy.

Characterization of readmission after allogeneic hematopoietic cell transplantation

S. Kurosawa, T. Fukuda, Y. Inamoto, 2021, Bone Marrow Transplantation.

Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders.

M. Hino, H. Koh, Masamichi Hashiba, 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Sinusoidal obstruction syndrome associated with disseminated toxoplasmosis involving the liver after allogeneic hematopoietic stem cell transplantation: A case report.

M. Hino, K. Norose, H. Kakeya, 2023, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

T-cell posttransplant lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

A. Maeshima, H. Taniguchi, S. Kurosawa, 2020, International Journal of Hematology.

Effect of graft cell dose on second transplantation from a haploidentical donor with post-transplantation cyclophosphamide for relapsed/refractory acute leukemia

M. Hino, H. Koh, Y. Nakashima, 2023, Bone marrow transplantation.

Successful treatment of proven coronavirus disease 2019-associated pulmonary aspergillosis with liposomal amphotericin B in a patient with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation

M. Hino, Tadaki Suzuki, H. Kakeya, 2022, Journal of Infection and Chemotherapy.

Fulminant Metastatic Cellulitis Caused by Stenotrophomonas Maltophilia Infection and Subsequent Candida Parapsilosis Fungemia After Cord Blood Transplantation.

M. Hino, H. Kakeya, H. Koh, 2023, Transplantation proceedings.

Rhinovirus/enterovirus identification by electron microscopy in lower respiratory tract infection in a patient with relapsed myelodysplastic syndrome after allogeneic hematopoietic cell transplantation and donor lymphocyte infusion.

M. Hino, M. Ohsawa, H. Koh, 2023, Transplant immunology.

Plasma Levels of Presepsin (Soluble CD14-subtype) as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancies.

M. Hino, H. Koh, Masamichi Hashiba, 2016, Internal medicine.

Pretransplant hepatomegaly is linked to relapse in patients with leukemia and myelodysplastic syndrome not in remission.

H. Koh, Y. Nakashima, H. Nakamae, 2024, International journal of hematology.

Isatuximab plus Pomalidomide and Dexamethasone in a Patient with Dialysis-Dependent Multiple Myeloma

K. Ohta, M. Hino, H. Koh, 2021, Chemotherapy.

Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.

H. Koh, Y. Nakashima, H. Nakamae, 2024, Annals of hematology.

A comparison of long-term outcomes by donor type in the era of post-transplantation cyclophosphamide for aggressive adult T-cell leukemia/lymphoma.

H. Koh, Y. Nakashima, H. Nakamae, 2024, Bone marrow transplantation.

Successful treatment with mesenchymal stem cells for steroid-refractory late-onset idiopathic pneumonia syndrome following allogeneic hematopoietic cell transplantation.

H. Koh, Y. Nakashima, H. Nakamae, 2024, Transplant immunology.

Intramural esophageal hematoma precipitated by acquired factor XI deficiency in a patient with relapsed T cell prolymphocytic leukemia after allogeneic hematopoietic cell transplantation

M. Hino, Y. Fujiwara, A. Higashimori, 2022, Annals of Hematology.